Vasoactive Inotropic Score compared to the sequential organ failure assessment cardiovascular score in intensive care
Acta Anaesthesiologica Scandinavica · 2023-10 · 67 (9) · 1219-1228
DOI: 10.1111/aas.14287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Anaesthesiologica Scandinavica, online erschienen am 05.06.2023. Verfasst von Anssi Pölkki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Intensive Care, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Organ Dysfunction Scores, Critical Care. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Einar och Karin Stroems stiftelse, Finska Läkaresällskapet, Kuopio University Hospital.
Themen: Intensivpflege
Abstract (Originalsprache)
Background
The cardiovascular component of the sequential organ failure assessment (cvSOFA) score may be outdated because of changes in intensive care. Vasoactive Inotropic Score (VIS) represents the weighted sum of vasoactive and inotropic drugs. We investigated the association of VIS with mortality in the general intensive care unit (ICU) population and studied whether replacing cvSOFA with a VIS‐based score improves the accuracy of the SOFA score as a predictor of mortality.
Methods
We studied the association of VIS during the first 24 h after ICU admission with 30‐day mortality in a retrospective study on adult medical and non‐cardiac emergency surgical patients admitted to Kuopio University Hospital ICU, Finland, in 2013–2019. We determined the area under the receiver operating characteristic curve (AUROC) for the original SOFA and for SOFA VISmax , where cvSOFA was replaced with maximum VIS (VIS max ) categories.
Results
Of 8079 patients, 1107 (13%) died within 30 days. Mortality increased with increasing VIS max . AUROC was 0.813 (95% confidence interval [CI], 0.800–0.825) for original SOFA and 0.822 (95% CI: 0.810–0.834) for SOFA VISmax , p < .001.
Conclusion
Mortality increased consistently with increasing VIS max . Replacing cvSOFA with VIS max improved the predictive accuracy of the SOFA score.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anaesthesiology and Intensive Care, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
- Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, Kuopio, Finland.
- Department of Anaesthesiology and Intensive Care, North Karelia Central Hospital, Joensuu, Finland.
ORCID-Profile: Anssi Pölkki, Pirkka T Pekkarinen, Pasi Lahtinen, Timo Koponen, Matti Reinikainen
Förderung
- Einar och Karin Stroems stiftelse
- Finska Läkaresällskapet
- Kuopio University Hospital
- University of Eastern Finland
- Kuopion Yliopistollinen Sairaala
- Itä-Suomen Yliopisto
Zitieren
APA
Pölkki, A., Pekkarinen, P. T., Lahtinen, P., Koponen, T., & Reinikainen, M. (2023). Vasoactive Inotropic Score compared to the sequential organ failure assessment cardiovascular score in intensive care. Acta Anaesthesiologica Scandinavica, 67(9), 1219-1228. https://doi.org/10.1111/aas.14287
Vancouver
Pölkki A, Pekkarinen PT, Lahtinen P, Koponen T, Reinikainen M. Vasoactive Inotropic Score compared to the sequential organ failure assessment cardiovascular score in intensive care. Acta Anaesthesiologica Scandinavica. 2023;67(9):1219-1228. doi:10.1111/aas.14287
BibTeX
@article{Plkki2023,
author = {Pölkki, Anssi and Pekkarinen, Pirkka T and Lahtinen, Pasi and Koponen, Timo and Reinikainen, Matti},
title = {Vasoactive Inotropic Score compared to the sequential organ failure assessment cardiovascular score in intensive care},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2023},
volume = {67},
number = {9},
pages = {1219--1228},
doi = {10.1111/aas.14287}
}
EUVIMED